secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001493152-23-030659
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience raises $7.0M in registered direct offering of 10M shares and warrants
--------------------------------------------------------------------------------

- Total gross proceeds of $7.0M from sale of 10M shares and warrants at $0.70/unit.
- Warrants exercisable after 6 months at $0.77/share for 5.5 years, with 4.99% ownership limitation.
- Investors include an institutional investor and an affiliate of the licensor of an early stage product candidate.
- Closing expected September 1, 2023; proceeds for general corporate purposes, including clinical trials and R&D.
- Offered under existing S-3 shelf registration statement; prospectus supplement to be filed with SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223030659/0001493152-23-030659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223030659/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer